• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Risk stratification for long-term outcome after elective coronary angioplasty: a multivariate analysis of 5,000 patients.

作者信息

Mick M J, Piedmonte M R, Arnold A M, Simpfendorfer C

机构信息

Department of Cardiology, Cleveland Clinic Foundation, Ohio.

出版信息

J Am Coll Cardiol. 1994 Jul;24(1):74-80. doi: 10.1016/0735-1097(94)90544-4.

DOI:10.1016/0735-1097(94)90544-4
PMID:8006285
Abstract

OBJECTIVES

We attempted to develop a statistical model to facilitate risk stratification for long-term outcome after elective coronary angioplasty.

BACKGROUND

Our understanding of factors related to long-term outcome after coronary angioplasty is limited. Adequate assessment of risk indexes could potentially lead to more appropriate use of percutaneous revascularization.

METHODS

We studied 5,000 consecutive patients and assessed 19 clinical and anatomic variables as predictors of long-term event-free survival. Events were defined as death of any cause, myocardial infarction, bypass surgery or repeat percutaneous transluminal coronary angioplasty. Cox proportional hazards models were used to develop an equation for predicting event-free survival in a subset of 4,000 patients. The equation was validated with the remaining 1,000 patients. Variables that were significantly associated with an adverse outcome in the multivariate model included age > 60 years, extent of disease, Canadian Cardiovascular Society functional class, previous coronary angioplasty, male gender, history of diabetes mellitus, history of hypertension and history of congestive heart failure.

RESULTS

The statistical model was used to develop a simplified scoring system, and the patients were assigned to three risk subgroups. Event-free survival curves for the three groups were significantly different (p = 0.0001). High risk patients had worse outcomes for each of the end points compared with low and moderate risk patients (p < 0.02).

CONCLUSIONS

We demonstrated that clinical and anatomic variables can be used to risk-stratify long-term outcome after angioplasty, that a simplified scoring system can be used for risk stratification and that high risk patients have a low event-free survival.

摘要

相似文献

1
Risk stratification for long-term outcome after elective coronary angioplasty: a multivariate analysis of 5,000 patients.
J Am Coll Cardiol. 1994 Jul;24(1):74-80. doi: 10.1016/0735-1097(94)90544-4.
2
Predicting early and intermediate-term outcome of coronary angioplasty in the elderly.
Circulation. 1993 Oct;88(4 Pt 1):1579-87. doi: 10.1161/01.cir.88.4.1579.
3
Is traditionally defined complete revascularization needed for patients with multivessel disease treated by elective coronary angioplasty? Multivessel Angioplasty Prognosis Study (MAPS) Group.
J Am Coll Cardiol. 1993 Nov 1;22(5):1289-97. doi: 10.1016/0735-1097(93)90532-6.
4
Importance of diabetes mellitus and systemic hypertension rather than completeness of revascularization in determining long-term outcome after coronary balloon angioplasty (the LDCMC registry). Lady Davis Carmel Medical Center.糖尿病和系统性高血压在决定冠状动脉球囊血管成形术(LDCMC注册研究)后的长期预后中的重要性,而非血管重建的完整性。戴维斯夫人卡梅尔医疗中心。
Am J Cardiol. 1998 Sep 1;82(5):547-53. doi: 10.1016/s0002-9149(98)00413-5.
5
Long-term survival after vascular surgery: specific influence of cardiac factors and implications for preoperative evaluation.血管手术后的长期生存:心脏因素的特定影响及对术前评估的意义
J Vasc Surg. 2004 Oct;40(4):752-60. doi: 10.1016/j.jvs.2004.07.038.
6
Percutaneous transluminal coronary angioplasty as a first revascularization procedure in single-, double- and triple-vessel coronary artery disease.经皮腔内冠状动脉成形术作为单支、双支和三支冠状动脉疾病首次血运重建手术的应用
J Am Coll Cardiol. 1995 Jul;26(1):142-51. doi: 10.1016/0735-1097(95)00136-n.
7
Correlation of residual stenosis immediately after coronary angioplasty with long-term prognosis.冠状动脉血管成形术后即刻残余狭窄与长期预后的相关性。
Cathet Cardiovasc Diagn. 1998 Mar;43(3):262-70. doi: 10.1002/(sici)1097-0304(199803)43:3<262::aid-ccd5>3.0.co;2-7.
8
Determinants of 2-year outcome after coronary angioplasty in patients with multivessel disease on the basis of comprehensive preprocedural evaluation. Implications for patient selection. The Multivessel Angioplasty Prognosis Study Group.基于全面术前评估的多支血管病变患者冠状动脉血管成形术后2年预后的决定因素。对患者选择的启示。多支血管血管成形术预后研究组
Circulation. 1991 Jun;83(6):1905-14. doi: 10.1161/01.cir.83.6.1905.
9
Influence of diabetes mellitus on early and late outcome after percutaneous transluminal coronary angioplasty.糖尿病对经皮腔内冠状动脉成形术后早期和晚期预后的影响。
Circulation. 1995 Feb 15;91(4):979-89. doi: 10.1161/01.cir.91.4.979.
10
Abnormal glucose tolerance, not small vessel diameter, is a determinant of long-term prognosis in patients treated with balloon coronary angioplasty.糖耐量异常而非小血管直径是接受球囊冠状动脉成形术治疗患者长期预后的决定因素。
Eur Heart J. 2000 Nov;21(21):1790-6. doi: 10.1053/euhj.2000.2181.

引用本文的文献

1
Impact of diabetes mellitus in patients undergoing contemporary percutaneous coronary intervention: Results from a Korean nationwide study.糖尿病患者行当代经皮冠状动脉介入治疗的影响:一项来自韩国全国性研究的结果。
PLoS One. 2018 Dec 10;13(12):e0208746. doi: 10.1371/journal.pone.0208746. eCollection 2018.
2
Stress echocardiogaphy: a useful test for assessing cardiac risk in diabetes.负荷超声心动图:评估糖尿病患者心脏风险的一项有用检查。
Vasc Health Risk Manag. 2009;5(1):1-7. Epub 2009 Apr 8.
3
Multiple predictors of coronary restenosis after drug-eluting stent implantation in patients with diabetes.
糖尿病患者药物洗脱支架植入术后冠状动脉再狭窄的多种预测因素。
Heart. 2006 Aug;92(8):1119-24. doi: 10.1136/hrt.2005.075960. Epub 2006 Jan 31.
4
Indications for percutaneous and surgical revascularisation: how far does the evidence base guide us?经皮和外科血管重建的适应症:循证依据能在多大程度上为我们提供指导?
Heart. 2003 May;89(5):565-70. doi: 10.1136/heart.89.5.565.
5
Effectiveness and cost effectiveness of single bolus treatment with abciximab (Reo Pro) in preventing restenosis following percutaneous transluminal coronary angioplasty in high risk patients.阿昔单抗(Reo Pro)单次推注治疗高危患者经皮腔内冠状动脉成形术后预防再狭窄的有效性及成本效益
Heart. 1998 Jan;79(1):12-7. doi: 10.1136/hrt.79.1.12.